(Q72585093)

English

Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody

scientific article published on 01 October 1993

Statements

Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit